6
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Clinical Use of Anticonvulsants: A Neurologist's Perspective

Pages 257-268 | Published online: 03 Jul 2009

  • Karceski S, Morrell M, Carpenter D. The expert consensus guideline series: treatment of epilepsy. Epilepsy Behav 2001:2 (6 suppl):A1-50.
  • Annegers JF. The epidemiology of epilepsy. In: Wyllie E, ed. The treatment of epilepsy: princples and practice. 3rd ed. Philadelphia: Lippincott Williams & Wilkins, 2001: 131-8.
  • Rosman NP, Colton T, Labazzo J, Gilbert PL, Gardella NB, Kaye EM, et al. A controlled trial of diazepam administered during febrile illnesses to prevent recurrence of febrile seizures. N Engl J Med 1993;329:79-84.
  • Annegers JF, Hauser WA, Lee JB, Rocca WA. Incidence of acute symptomatic seizures in Rochester, Minnesota, 1935-1984. Epilepsia 1995;36:327-33.
  • Hauser WA, Annegers JF, Kurland LT. Incidence of epilepsy and unprovoked seizures in Rochester, Minnesota: 1936-1984. Epilepsia 1993;34:453-68.
  • Bromfield EB. Somatosensory, special sensory, and autonomie phenomena in seizures. Semin Neurol 1991;11:91-9.
  • Devinsky O, Luciano D. Psychic phenomena in seizures. Semin Neurol 1991;11:100-9.
  • Porter RJ. Disorders of consciousness and associated complex behaviors. Semin Neurol 1991;11:110-7.
  • Theodore WH, Porter RJ, Albert P, Kelley K, Bromfield E, Devinsky O, et al. The secondarily generalized tonic-clonic seizure: a videotape analysis. Neurology 1994;44:1403-7.
  • Commission on Classification and Terminology of the International League against Epilepsy. Proposal for the revised clinical and electroencephalographic classification of epileptic seizures. Epilepsia 1981;22:489-601.
  • Commission on Classification and Terminology of the International League against Epilepsy. Proposal for the revised classification of epilepsies and epileptic syndromes. Epilepsia 1989;30:389-99.
  • Bromfield EB. Diagnosis and classification of epilepsy. In: Samuels MA, Feske S, eds. Office practice of neurology. 2nd ed. Philadelphia: Churchill-Livingetone, 2003:928-32.
  • Engel J Jr. A proposed diagnostic scheme for people with epileptic seizures and with epilepsy: report of the ILAE task force on classification and terminology. Epilepsia 2001;43:796-803.
  • Kaneko S, Okada M, Iwasa H, Yamakawa K, Hirose S. Genetics of epilepsy: current status and perspectives. Neurosci Res 2002;44:11-30.
  • Serratosa JM. Juvenile myoclonic epilepsy. In: Wyllie E, ed. The treatment of epilepsy: principles and practice. 3rd ed. Philadelphia: Lippincott Williams & Wilkins, 2001:491-507.
  • Mendez MF, Cummings JL, Benson DF. Depression in epilepsy. Significance and phenomenology. Arch Neurol 1986;43:766-70.
  • Devinsky O, Najjar S. Evidence against the existence of a temporal lobe epilepsy personality syndrome. Neurology 1999;53(5 suppl 2):S13-25.
  • Engel J Jr. Current concepts: surgery for seizures. N Engl J Med 1996;10:647-62.
  • Wiebe S, Blume WT, Girvin JP, Eliasziw M. A randomized, controlled trial of surgery for temporal-lobe epilepsy. N Engl J Med 2001;345:311-8.
  • Browne TR, Hohnes GL. Epilepsies with childhood onset & Epilepsies with juvenile and adult onset. In: Handbook of epilepsy. 2nd ed. Philadelphia: Lippincott Williams & Wilkins, 2000:83-106.
  • Bromfield E, Henderson G. Seizures and cerebrovascular disease. In: Ettinger AB, Devinsky O, eds. Managing epilepsy and co-existing disorders. Boston: Butterworth-Heinemann, 2002:269-90.
  • Devinsky O. The differential diagnosis of epilepsy. Semin Neurol 1990; 10:321-7.
  • Gotman J, Maraani MG. Electroencephalographic spiking activity, drug levels, and seizure occurrence in epileptic patients. Ann Neurol 1985;17:597-601.
  • Browne TR, Holmes GL. Situation-related epilepsies. In: Handbook of epilepsy. 2nd ed. Philadelphia: Lippincott Williams & Wilkins, 2000:107-9.
  • D'Onofrio G, Rathlev NK, Ulrich AS, Fish SS, Freedland ES. Lorazepam for the prevention of recurrent seizures related to alcohol. N Engl J Med 1999;340:915-9.
  • Malcolm R, Myrick H, Brady KT, Ballenger JC. Update on anticonvulsants for the treatment of alcohol withdrawal. Am J Addict 2001;10(suppl):16-23.
  • Berg AT, Shinnar S. The risk of seizure recurrence following a first unprovoked seizure: a quantitative review. Neurology 1991;41:965-72.
  • First Seizure Clinical Trial Group. Randomized clinical trial on the efficacy of antiepileptic drugs in reducing the risk of relapse after a first unprovoked generalized tonic-clonic seizure. Neurology 1993;43:478-83.
  • Bromfield EB. EEG and evoked potentials. In: Samuels MA, Feske S, eds. Office practice of neurology. 2nd ed. Philadelphia: Churchill-Livingstone, 2003:187-97.
  • Walczak TS, Jayakar P. Interictal EEG. In: Engel J Jr, Pedley TA, eds. Epilepsy: a comprehensive textbook. Philadelphia: Lippincott-Raven, 1997:831-48.
  • French JA. Antiepileptic drug development. In: Wyllie E, ed. The treatment of epilepsy: principles and practice. 3rd ed. Philadelphia: Lippincott Williams & Wilkins, 2001: 719-27.
  • Brodie MJ, Dichter MA. Antiepileptic drugs. N Engl J Med 1996;334:168-75.
  • French JA, Schachter SC, eds. A workshop on antiepileptic drug monotherapy indications. Epilepsia 2002;43(suppl 10):3-27.
  • Callaghan N, Kenny RA, O'Neill B, Crowley M, Goggin T. A prospective study between carbamazepine, phenytoin, and sodium valproate as monotherapy in previously untreated and recently diagnosed patients with epilepsy. J Neurol Neurosurg Psychiat 1985;48:639-44.
  • Mattson RH, Cramer JA, Colline JF, Smith DB, DelgadoEscueta AV, Browne TR, et al. Comparison of carbamazepine, phenobarbital, phenytoin and primidone in partial and secondary generalized tonic-clonic seizures. N Engl J Med 1985; 313:145-61.
  • Mattson RH, Cramer JA, Colline JF. A comparison of valproate with carbamazepine for the treatment of complex partial seizures and secondarily generalized tonic-clonic seizures in adults. N Engl J Med 1992;327:765-71.
  • Brodie MJ, Richens A, Yun AW. Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy. Lancet 1995;345:476-9.
  • Steiner TJ, Dellaportas CI, Findley LJ, Gross M, Gibberd FB, Perkin GD, et al. Lamotrigine monotherapy in newly diagnosed untreated epilepsy. Epilepsia 1999;40:601-7.
  • Brodie MJ, Chadwick DW, Anhut H, Otte A, Messmer SL, Maton S, et al. (Gabapentin Study Group). Gabapentin versus lamotrigine monotherapy: a double-blind comparison in newly diagnosed epilepsy. Epilepsia 2002;43:993-1000.
  • Dam M, Ekberg R, Loyning Y, Waltimo O, Jakobsen K. A doubleblind study comparing oxcarbazepine and carbamazepine in patients with newly diagnosed, previously untreated epilepsy. Epilepsy Res 1989;3:70-6.
  • Guerreiro MM, Vigonius U, Pohlmann H, de Manreza ML, Fejerman N, Antoniuk SA, et al. A double-blind controlled clinical trial of oxcarbazepine versus phenytoin in children and adolescents with epilepsy. Epilepsy Res 1997;26:205-13.
  • Christe WW, Kramer G, Vigonius U, Pohlmann H, Steinhoff BJ, Brodie MJ, et al. A double-blind study controlled clinical trial: oxcarbazepine versus sodium valproate in adults with newly
  • Kwan P, Brodle MJ. Early identification of refractory epilepsy. N Engl J Med 2000;342:314-9.
  • Devinsky O. Patients with refractory seizures. N Engl J Med 1999;340:1566-70.
  • Marson AG, Kadir ZA, Hutton JL, Chadwick DW. The new antiepileptic drugs: a systematic review of their efficacy and tolerability. Epilepsia 1997;38:859-80.
  • Browne TR, Holmes GL. Epilesy. N Engl J Med 2001; 344:1146-51.
  • French JA. The role of new antiepileptic drugs. Am J Manag Care 2001;7(7 suppl):S209-14.
  • Morrell MJ. Antiepileptic medications for the treatment of epilepsy. Semin Neurol 2002;22:247-58.
  • Schmidt D. The clinical impact of new antiepileptic drugs after a decade of use in epilepsy. Epilepsy Res 2002;50:21-32.
  • Sato S, White BG, Penry JK, Dreifuss FE, Sackellares JC, Kupferberg HJ. Valproic acid versus ethosuximide in the treatment of absence seizures. Neurology 1982;32:157-63.
  • Bromfield EB. Ethosuximide and other succinimides. In: Engel J Jr, Pedley TA, eds. Epilepsy: a comprehensive textbook. Philadelphia: Lippincott-Raven, 1997:1503-8.
  • Choi H, Morrell MJ. Review of lamotrigine and its clinical applications in epilepsy. Expert Opin Pharmacother 2003;4: 243-51.
  • Perucca E, Gram L, Avanzini G, Dulac O. Antiepileptic drugs as a cause of worsening seizures. Epilepsia 1998;39: 5-17.
  • Felbamate Study Group in Lennox-Gastaut. Efficacy of felbamate in childhood epileptic encephalopathy (Lennox-Gastaut syndrome). N Engl J Med 1993;328:29-33.
  • Sachdeo RC, Glauser TA, Ritter FA, Reife R, Lim P, Pledger G. A double-blind, randomized trial of topiramate in Lennox-Gastaut syndrome. Neurology 1999;52:1882-7.
  • Motte J, Trevathan E, Arvidsson JR, Barrera MN, Mullens EL, Manasco P. Lamotrigine for generalized seizures associated with the Lennox-Gastaut syndrome. N Engl J Med 1997;337:1807-12.
  • Pellock JM. Felbamate in epilepsy therapy: evaluating the risks. Drug Saf 1999;21:225-39.
  • Lesser RP, Pippenger CE, Luders H, Dinner DS. High-dose monotherapy in treatment of intractable seizures. Neurology 1984;34:707-11.
  • Dodson E. Level off. Neurology 1989;39:1009-10.
  • Schmidt D, Richter K. Alternative single anticonvulsant drug therapy for refractory epilepsy. Ann Neurol 1986;19:85-7.
  • Schmidt D. Strategies to prevent overtreatment with antiepileptic drugs in patients with epilepsy. Epilepsy Res 2002;52:61-9.
  • Perucca E. Overtreatment in epilepsy: adverse consequences and mechanisms. Epilepsy Res 2002;52:25-33.
  • Bourgeois BFD. Long-term therapy with antiepileptic drugs. In: Wyllie E, ed. The treatment of epilepsy: principles and practice. 3rd ed. Philadelphia: Lippincott Williams & Wilkins, 2001:769-74.
  • Ferrendelli JA. Relating pharmacology to clinical practice: the pharmacologie basis of rational polytherapy. Neurology 1995;45(suppl 2):S12-6.
  • Devinsky O, Cramer J, eds. Assessing quality of life in epilepsy: development of a new inventory. Epilepsia 1993;34(suppl 4).
  • Cramer J, Arrigo C, Van Hammee G, Bromfield E. Comparison between the QOLIE-31 and derived QOLIE-IO in a clinical trial of levetiracetam. Epilepsy Res 2000;41:29-38.
  • Farhat G, Yamout B, Mikati MA, Demirjian S, Sawaya R, El-Hajj Fuleihan G. Effect of antiepileptic drugs on bone density in ambulatory patients. Neurology 2002;58:1348-53.
  • Sato Y, Hondo I, Ishida S, Motooka H, Takayama K, Tomita Y, et al. Decreased bone mass and increased bone turnover with valproate therapy in adults with epilepsy. Neurology 2001;57: 445-9.
  • Kasarskris EJ, Kuo CS, Berger R, Nelson KR. Carbamazepineinduced cardiac dysfunction. Characterization of two distinct clinical syndromes. Arch Intern Med 1992;152:186-91.
  • Chan TY. Drug-induced syndrome of inappropriate antidiuretic hormone secretion. Causes, diagnosis and management. Drugs Aging 1997;ll:27-44.
  • Brodie MJ, Overstall PW, Giorgi L. Multicentre, doubleblind, randomized comparison between lamotrigine and carbamazepine in elderly patients with newly diagnosed epilepsy. Epilepsy Res 1999;37:81-7.
  • Annegers JF, Hauser WA, Elveback LR. Remission of seizures and relapse in patients with epilepsy. Epilepsia 1979;20:729-37.
  • Shinnar S, Vining EP, Mellits ED, D'Souza BJ, Holden K, Baumgardner RA, et al. Discontinuing antiepileptic medication in children with epilepsy after two years without seizures. N Engl J Med 1985;313:976-80.
  • Callaghan N, Garrett A, Goggin T. Withdrawal of anticonvulsant drugs in patients free of seizures for two years. N Engl J Med 1988;318:942-6.
  • Medical Research Council Antiepileptic Drug Withdrawal Study Group. Randomised study of antiepileptic drug withdrawal in patients in remission. Lancet 1991;337:1175-80.
  • Britton JW. Antiepileptic drug withdrawal: literature review. Mayo Clin Proc 2002;77:1378-88.
  • Heck C, Helmers SL, DeGiorgio CM. Vagus nerve stimulation therapy, epilepsy, and device parameters: scientific basis and recommendations for use. Neurology 2002;59(6 suppl 4): S31-7.
  • Wheless JW, Baumgartner J, Ghanbari C. Vagus nerve stimulation and the ketogenic diet. Neurol Clin 2001; 19:371-407.
  • Yerby MS. Risks of pregnancy in women with epilepsy. Epilepsia 1992;33(suppl l):S23-27.
  • Morrell MJ. Guidelines for the care of women with epilepsy. Neurology 1998;51(suppl 4):S21-27.
  • Crawford P. Epilepsy and pregnancy. Seizure 2002;11(suppl A):212-9.
  • McAuley JW, Anderson GD. Treatment of epilepsy in women of reproductive age: pharmacokinetic considerations. Clin Pharmacokmet 2002;41:559-79.
  • Bauer J, Isojarvi JI, Herzog AG, Reuber M, Poison D, Tauboll E, et al. Reproductive dysfunction in women with epilepsy: recommendations for evaluation and management. J Neurol Neurosurg Psychiatry 2002;73:121-5.
  • Holmes LB, Harvey EA, Coull BA, Huntington KB, Khoshbin S, Hayes AM, et al. The teratogenicity of anticonvulsant drugs. N Engl J Med 2001;344:1132-8.
  • Tennis P, Eldridge RR; International Lamotrigine Pregnancy Registry Scientific Advisory Committee. Preliminary results on pregnancy outcomes in women using lamotrigine. Epilepsia 2002;43:1161-7.
  • Tran TA, Leppik IE, Blesi K, Sathanandan ST, Remmel R. Lamotrigine clearance during pregnancy. Neurology 2002;59:251-6.
  • Krishnamoorthy ES, Trimble MR, Sander JW, Kanner AM. Forced normalization at the interface between epilepsy and psychiatry. Epilepsy Behav 2002;3:303-8.
  • Kanner AM, Palac S. Neuropsychiatrie complications of epilepsy. Curr Neurol Neurosci Rep 2002;2:365-72.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.